Medicale MCLE Income Statement (2020-2025)

MCLE
$0.00 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT
Reported Financials

Medicale Quarterly Income Statement

Periods 22 quarters
Latest Dec 2025

Medicale reported net income of -$0.01M for the quarter ended Dec 2025. This income statement covers 22 quarters of results from Sep 2020 through Dec 2025, standardized by Business Quant from the company’s SEC filings.

Income Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating items
Selling, General & AdministrativeSG&A
0.01M0.01M0.01M0.02M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.02M0.01M0.01M0.02M0.01M0.01M0.00M0.01M0.00M
Operating ExpensesOpex
0.01M0.01M0.01M0.02M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.02M0.01M0.01M0.02M0.01M0.01M0.00M0.01M0.00M
Operating IncomeOp. Inc
-0.01M-0.01M-0.01M-0.02M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.02M-0.01M-0.01M-0.02M-0.01M-0.01M-0.00M-0.01M-0.00M
EBIT
-0.01M-0.01M-0.01M-0.02M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.02M-0.01M-0.01M-0.02M-0.01M-0.01M-0.00M-0.01M-0.00M
Non-operating items
Non Operating Interest Expenses
961.000.00M0.00M0.00M0.00M0.00M0.00M0.00M
Net income details
EBT
-0.01M-0.01M-0.01M-0.02M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.02M-0.01M-0.01M-0.02M-0.02M-0.01M-0.01M-0.01M-0.01M
Profit After TaxPAT
-0.01M-0.01M-0.01M-0.02M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.02M-0.01M-0.01M-0.02M-0.02M-0.01M-0.01M-0.01M-0.01M
Income from Continuing OperationsIncome (Continuing)
-0.01M-0.01M-0.01M-0.02M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.02M-0.01M-0.01M-0.02M-0.02M-0.01M-0.01M-0.01M-0.01M
Income from Discontinued OperationsIncome (Discontinued)
-600.00-600.00-600.00-600.00455.00
Consolidated Net IncomeConsol Net Inc.
-0.01M-0.01M-0.01M-0.02M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.02M-0.01M-0.01M-0.02M-0.02M-0.01M-0.01M-0.01M-0.01M
Income towards Parent CompanyParent Net Inc
-0.01M-0.01M-0.01M-0.02M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.02M-0.01M-0.01M-0.02M-0.02M-0.01M-0.01M-0.01M-0.01M
Net Income towards Common StockholdersNet Income
-0.01M-0.01M-0.01M-0.02M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.02M-0.01M-0.01M-0.02M-0.02M-0.01M-0.01M-0.01M-0.01M
Additional items
EPS (Basic)
0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
EPS (Diluted)
0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Shares Outstanding
4.28M5.92M3.62M5.92M5.92M5.92M5.92M5.92M5.92M5.92M5.92M5.92M5.92M5.92M5.92M5.92M5.92M5.92M5.92M5.92M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
5.92M3.62M5.92M5.92M5.92M5.92M5.92M5.92M5.92M5.92M5.92M5.92M5.92M5.92M5.92M5.92M5.92M5.92M5.92M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
4.28M5.92M3.62M5.92M5.92M5.92M5.92M5.92M5.92M5.92M5.92M5.92M5.92M5.92M5.92M5.92M5.92M5.92M5.92M5.92M
EBITDA
-0.01M-0.01M-0.01M-0.02M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.02M-0.01M-0.01M-0.02M-0.01M-0.01M-0.00M-0.01M-0.00M
Interest ExpensesInt Expense
961.000.00M0.00M0.00M0.00M0.00M0.00M0.00M